Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
prednisone
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(24)
News
Trials
Company:
Generic mfg.
Drug class:
Steroid receptor agonist
Related drugs:
‹
dexamethasone injection (0)
dexamethasone injection (0)
›
Associations
(24)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
prednisone + thalidomide + melphalan
Sensitive: A1 - Approval
prednisone + thalidomide + melphalan
Sensitive
:
A1
prednisone + thalidomide + melphalan
Sensitive: A1 - Approval
prednisone + thalidomide + melphalan
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
docetaxel + prednisone
Sensitive: A1 - Approval
docetaxel + prednisone
Sensitive
:
A1
docetaxel + prednisone
Sensitive: A1 - Approval
docetaxel + prednisone
Sensitive
:
A1
No biomarker
Thymic Carcinoma
No biomarker
Thymic Carcinoma
prednisone
Sensitive: A2 - Guideline
prednisone
Sensitive
:
A2
prednisone
Sensitive: A2 - Guideline
prednisone
Sensitive
:
A2
No biomarker
Thymoma
No biomarker
Thymoma
prednisone
Sensitive: A2 - Guideline
prednisone
Sensitive
:
A2
prednisone
Sensitive: A2 - Guideline
prednisone
Sensitive
:
A2
No biomarker
Thymic Carcinoma
No biomarker
Thymic Carcinoma
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
No biomarker
Thymoma
No biomarker
Thymoma
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
No biomarker
Acute Lymphocytic Leukemia
No biomarker
Acute Lymphocytic Leukemia
vincristine + prednisone
Sensitive: A2 - Guideline
vincristine + prednisone
Sensitive
:
A2
vincristine + prednisone
Sensitive: A2 - Guideline
vincristine + prednisone
Sensitive
:
A2
No biomarker
Acute Lymphocytic Leukemia
No biomarker
Acute Lymphocytic Leukemia
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive
:
A2
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive
:
A2
No biomarker
T Acute Lymphoblastic Leukemia
No biomarker
T Acute Lymphoblastic Leukemia
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive
:
A2
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive
:
A2
No biomarker
B Acute Lymphoblastic Leukemia
No biomarker
B Acute Lymphoblastic Leukemia
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive
:
A2
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase
Sensitive
:
A2
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
FBXW7 mutation
T Acute Lymphoblastic Leukemia
FBXW7 mutation
T Acute Lymphoblastic Leukemia
prednisone
Resistant: C3 – Early Trials
prednisone
Resistant
:
C3
prednisone
Resistant: C3 – Early Trials
prednisone
Resistant
:
C3
DDR
Prostate Cancer
DDR
Prostate Cancer
abiraterone acetate + prednisone
Resistant: C3 – Early Trials
abiraterone acetate + prednisone
Resistant
:
C3
abiraterone acetate + prednisone
Resistant: C3 – Early Trials
abiraterone acetate + prednisone
Resistant
:
C3
CYB5A rs1790834
Prostate Cancer
CYB5A rs1790834
Prostate Cancer
prednisone
Resistant: C3 – Early Trials
prednisone
Resistant
:
C3
prednisone
Resistant: C3 – Early Trials
prednisone
Resistant
:
C3
NOTCH1 L1574Q
T Acute Lymphoblastic Leukemia
NOTCH1 L1574Q
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 V1577E
T Acute Lymphoblastic Leukemia
NOTCH1 V1577E
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 L1600Q
T Acute Lymphoblastic Leukemia
NOTCH1 L1600Q
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 L1585R
T Acute Lymphoblastic Leukemia
NOTCH1 L1585R
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 V1577A
T Acute Lymphoblastic Leukemia
NOTCH1 V1577A
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 L1600P
T Acute Lymphoblastic Leukemia
NOTCH1 L1600P
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 L1574P
T Acute Lymphoblastic Leukemia
NOTCH1 L1574P
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 F1592S
T Acute Lymphoblastic Leukemia
NOTCH1 F1592S
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 F1592C
T Acute Lymphoblastic Leukemia
NOTCH1 F1592C
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
FOXO1 underexpression
Childhood B Acute Lymphoblastic Leukemia
FOXO1 underexpression
Childhood B Acute Lymphoblastic Leukemia
prednisone
Resistant: D – Preclinical
prednisone
Resistant
:
D
prednisone
Resistant: D – Preclinical
prednisone
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login